Cue Health, a San Diego company with a home testing kit for COVID-19, filed for a $180 million IPO on NASDAQ that values the company at $2 billion. Shanghai 's Decheng Capital participated in several Cue fundraisings including the company's $235 million round in May. Cue intends to build a broad platform to address a user's healthcare needs. The company's tests consist of a single-use cartridge that is compatible with the Cue Reader and sends the results to Cue's healthcare app on a smart phone. More details.... Share this with colleagues: // //